SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001358403-17-000091
Filing Date
2017-06-15
Accepted
2017-06-15 16:35:40
Documents
1
Period of Report
2017-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_149755892545494.html 4  
1 FORM 4 wf-form4_149755892545494.xml 4 3906
  Complete submission text file 0001358403-17-000091.txt   5426
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address INCYTE CORPORATION EXPERIMENTAL STATION RTE 141 & HENRY CLAY RD. BLDG E336 WILMINGTON DE 19880
Business Address
Daly James M (Reporting) CIK: 0001560782 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36783 | Film No.: 17913887